Skip to main
HTFL

HeartFlow Inc (HTFL) Stock Forecast & Price Target

HeartFlow Inc (HTFL) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

HeartFlow is experiencing strong growth with a 41% increase in revenues and a 90bps improvement in gross margins. This trend is expected to continue, with the company projecting 4Q25 revenues to be consistent with 3Q25 and a forecast of $211MM for 2026, driven by strong utilization of their core FFR-CT business and the potential for additional revenue from their plaque analysis business. With a planned expansion into new markets and a conservative approach to revenue projections, the company's outlook remains positive for the future.

Bears say

HeartFlow is currently operating at a significant loss and is not projected to achieve profitability in the foreseeable future, making it a high-risk investment. The majority of the company's revenue is currently derived from one product, FFR CT Analysis, and the success of its second product, Plaque Analysis, is uncertain. The company's success is also reliant on the adoption of its technology by healthcare providers, and there is significant competition and uncertainty surrounding reimbursement and payment for the company's services. Additionally, HeartFlow is currently under investigation by the US Department of Justice, which could result in a financial settlement that could significantly impact the company's financials.

HeartFlow Inc (HTFL) has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HeartFlow Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HeartFlow Inc (HTFL) Forecast

Analysts have given HeartFlow Inc (HTFL) a Buy based on their latest research and market trends.

According to 5 analysts, HeartFlow Inc (HTFL) has a Buy consensus rating as of May 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $38.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $38.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HeartFlow Inc (HTFL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.